# The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines

> **NCT04391400** · — · UNKNOWN · sponsor: **Invivoscribe, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- SARS-CoV-2

## Interventions

- **DIAGNOSTIC_TEST:** nasal pharyngeal (NP) swab samples
- **DIAGNOSTIC_TEST:** peripheral blood draw

## Key facts

- **NCT ID:** NCT04391400
- **Lead sponsor:** Invivoscribe, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04391400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04391400, "The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT04391400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*